Study finds pancreatic cancer gene in smokers:
This article was originally published in Clinica
Executive Summary
A study has found that heavy smokers who lack both copies of a gene called GSTT1 may run a higher risk of developing pancreatic cancer. Male smokers lacking the gene, which encodes for glutathione S-transferase enzymes, had a 3.2-fold increased relative risk of developing pancreatic cancer compared with non-smokers who have both copies of the gene. Notably, female smokers had a 5-fold increase in risk. The findings, by Dr Eric Duell and colleagues of the Harvard School of Public Health, appear in the Journal of the National Cancer Institute (February 20).
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.